Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03845738 · ClinicalTrials.gov registry record
Retrospective Evaluation of Clinical Performance of the Astra Tech Implant System EV When Used in Everyday Practice
A clinical trial, sponsored by Dentsply Sirona Implants and Consumables.
- Completed
- Registry status
- 208
- Enrollment target
NCT03845738: Completed study, sponsored by Dentsply Sirona Implants and Consumables.
NCT03845738 is a clinical trial that has completed, run by Dentsply Sirona Implants and Consumables. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03845738 has completed, sponsored by Dentsply Sirona Implants and Consumables.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
This study is designed as a retrospective, multi-center study. The study population consist of subjects who received one or more OsseoSpeed EV implants during the period January 1st 2015 to December 31st 2016. Two hundred subjects will be enrolled, approximately 25-30 subjects per site. The study includes retrospective data collection from subjects' medical records and data collection from one prospective study visit with a clinical examination.
Primary Outcome
Survival defined as implant in situ at time of the follow-up visit. Primary analysis performed on implant level.
Interventions
- DEVICE OsseoSpeed EV implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2019-08-12 |
| Est. Completion | 2020-12-14 |
What the finished NCT03845738 record still lists
NCT03845738 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OsseoSpeed EV implant is the first listed.
NCT03845738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03845738 about?
NCT03845738 is a clinical study titled "Retrospective Evaluation of Clinical Performance of the Astra Tech Implant System EV When Used in Everyday Practice". This study is designed as a retrospective, multi-center study. The study population consist of subjects who received one or more OsseoSpeed EV implants during the period January 1st 2015 to December 31st 2016. Two hundred subjects will be enrolled, approximately 25-30 subjects per site. The study in...
What is the current status of trial NCT03845738?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2019-08-12. Estimated completion is 2020-12-14.
What interventions are being tested in trial NCT03845738?
The interventions under investigation include: OsseoSpeed EV implant (DEVICE).
Who is sponsoring clinical trial NCT03845738?
This trial is sponsored by Dentsply Sirona Implants and Consumables, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI